샘플 요청 목록

 카트 문의
시장보고서
상품코드
1762469

세계의 핵산 증폭 검사(NAAT) 시장 : 시장 규모, 점유율 및 동향, 업계 분석(유형별·용도별·최종 용도별, 지역별), 예측(2025-2034년)

Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 125 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 핵산 증폭 검사(NAAT) 시장 규모는 2034년까지 288억 6,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

핵산 증폭 검사(NAAT)는 생물학적 시료에서 DNA와 RNA를 포함한 특정 유전 물질을 정확히 찾아내도록 설계된 강력한 분자 기술군을 구성합니다. 이러한 검사의 기본 원리는 미량의 표적 핵산을 검출 가능한 수준까지 증폭하는 능력에 있습니다. 이러한 증폭은 조기 및 정확한 진단에 필요한 높은 민감도를 달성하는 데 필수적이며, 특히 저농도로 존재하는 병원체를 다룰 때나 그렇지 않으면 발견되지 않을 수 있는 미묘한 유전적 변이를 식별할 때 유용하게 사용됩니다. 다양한 의학 분야의 임상적 판단에 매우 중요한 역할을 하고 있습니다.

새로운 병원균의 출현과 기존 병원균의 부활 등 전염병의 위협이 끊이지 않기 때문에 효과적인 질병 관리와 봉쇄를 위해서는 NAAT와 같은 고감도 진단 도구를 널리 채택할 필요가 있습니다. 또한, 유전성 질환의 유병률 증가와 종양학에서 분자진단의 적용 확대는 NAAT 시장 수요 추세를 촉진하는 중요한 요인으로 작용하고 있습니다. 분자 기술의 발전과 더 빠르고, 사용하기 쉽고, 비용 효율적인 NAAT 플랫폼의 개발은 NAAT의 적용 범위와 이용 편의성을 확대하여 이러한 중요한 진단 분석의 발전에 더욱 기여하고 있습니다.

핵산 증폭 검사(NAAT) 시장 : 분석 개요

유형별로는 중합효소연쇄반응(PCR) 검사가 높은 특이성, 민감도, 다양한 진단 분야에 대한 폭넓은 적용성으로 인해 2024년 세계 최대 점유율을 차지했습니다. 등온 핵산 증폭 기술(INAAT) 검사는 신속한 현장 검사 솔루션에 대한 수요 증가로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예측됩니다.

용도별로는 감염 검사 분야가 2024년 가장 큰 점유율을 차지했으며며, 이는 NAAT가 다양한 감염 요인의 진단 및 모니터링에 광범위하게 사용되고 있기 때문으로 분석됩니다. 종양 검사는 암 관리 및 개인 맞춤형 의료 접근법에서 분자진단의 채택이 증가함에 따라 가장 빠르게 성장하는 응용 분야가 될 것으로 예측됩니다.

최종 용도별로는 2023년 핵산 증폭 검사(NAAT) 시장에서 가장 큰 점유율을 차지한 부문은 중앙 실험실 및 참조 실험실 부문입니다. 병원 분야는 환자 치료의 신속성과 개선을 위해 병원 내 첨단 분자진단의 통합이 진행됨에 따라 가장 높은 성장률을 보일 것으로 예측됩니다.

지역별로는 북미가 2024년 시장에서 가장 큰 점유율을 차지했습니다. 아시아태평양의 핵산 증폭 검사(NAAT) 시장은 예측 기간 동안 가장 높은 성장률을 나타낼 것으로 예측됩니다.

이 시장에서 활발하게 사업을 전개하고 있는 주요 기업으로는 F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc. Dickinson and Company(BD), Siemens Healthineers AG, Danaher Corporation(Cepheid), Hologic, Inc. 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 분석 방법

제4장 세계의 핵산 증폭 검사(NAAT) 시장 인사이트

  • 시장 현황
  • 핵산 증폭 검사(NAAT) 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTLE 분석
  • 핵산 증폭 검사(NAAT) 시장 이용 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 핵산 증폭 검사(NAAT) 시장 : 유형별

  • 주요 분석 결과
  • 서론
  • PCR 검사
  • INAAT 검사
  • LCR 검사

제6장 세계의 핵산 증폭 검사(NAAT) 시장 : 용도별

  • 주요 분석 결과
  • 서론
  • 감염증 검사
  • Deep Tensor
  • 종양 검사
  • 유전자 및 미토콘드리아 질환 검사
  • 기타

제7장 세계의 핵산 증폭 검사(NAAT) 시장 : 최종 용도별

  • 주요 분석 결과
  • 서론
  • 병원
  • 중앙 검사실
  • 참고 검사실
  • 기타

제8장 세계의 핵산 증폭 검사(NAAT) 시장 : 지역별

  • 주요 분석 결과
  • 서론
    • 핵산 증폭 검사(NAAT) 시장 분석 : 지역별(2020-2034년)
  • 북미
    • 북미 : 유형별(2020-2034년)
    • 북미 : 용도별(2020-2034년)
    • 북미 : 최종 용도별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 유형별(2020-2034년)
    • 유럽 : 용도별(2020-2034년)
    • 유럽 : 최종 용도별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 유형별(2020-2034년)
    • 아시아태평양 : 용도별(2020-2034년)
    • 아시아태평양 : 최종 용도별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 유형별(2020-2034년)
    • 중동 및 아프리카 : 용도별(2020-2034년)
    • 중동 및 아프리카 : 최종 용도별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 유형별(2020-2034년)
    • 라틴아메리카 : 용도별(2020-2034년)
    • 라틴아메리카 : 최종 용도별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 사업 확대 및 기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company(BD)
  • bioMerieux S.A.
  • Danaher Corporation(Cepheid)
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
LSH 25.07.14

The global nucleic acid amplification testing market size is expected to reach USD 28.86 billion by 2034, according to a new study by Polaris Market Research. The report "Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Nucleic acid amplification testing, or NAAT, constitutes a powerful suite of molecular techniques designed to pinpoint specific genetic material, encompassing both DNA and RNA, within a biological specimen. The fundamental principle of these tests lies in their capacity to amplify even trace amounts of target nucleic acids to detectable levels. This amplification is essential for achieving the high sensitivity required for early and accurate diagnosis, particularly when dealing with pathogens present in low concentrations or identifying subtle genetic variations that might otherwise go unnoticed. The precision and sensitivity offered by NAAT have established it as a cornerstone in modern diagnostics, playing a pivotal role in clinical decision-making across a spectrum of medical disciplines.

The persistent threat of infectious diseases, including the emergence of novel pathogens and the resurgence of existing ones, necessitates the widespread adoption of sensitive diagnostic tools such as NAAT for effective disease management and containment. Furthermore, the increasing prevalence of genetic disorders and the expanding application of molecular diagnostics in oncology are significant drivers for the market demand trends of NAAT. Ongoing advancements in molecular technologies, leading to the development of more rapid, user-friendly, and cost-effective NAAT platforms, are also broadening their applicability and accessibility, further contributing to the development of these crucial diagnostic assays.

Nucleic Acid Amplification Testing Market Report Highlights:

By type, the polymerase chain reaction (PCR) tests segment held the largest share globally in 2024 due to their high specificity, sensitivity, and broad applicability across various diagnostic areas. Isothermal nucleic acid amplification technology (INAAT) tests are anticipated to exhibit the highest growth rate during the forecast period, driven by the increasing demand for rapid and point-of-care testing solutions.

By application, the infectious disease testing segment constituted the largest application segment in 2024, fueled by the widespread use of NAAT for diagnosing and monitoring a wide array of infectious agents. Oncology testing is expected to be the fastest-growing application segment, driven by the increasing adoption of molecular diagnostics in cancer management and personalized medicine approaches.

By end use, the central and reference laboratories segment accounted for the largest share of the nucleic acid amplification testing market in 2023, attributed to the high volume of tests processed in these facilities and their role as key hubs for specialized testing. The hospitals segment is projected to demonstrate the highest growth rate, driven by the increasing integration of advanced molecular diagnostics within hospital settings for rapid and improved patient care.

By region, North America held the largest share of the market in 2024. The Asia Pacific nucleic acid amplification testing market is projected to record the highest growth rate during the forecast period.

A few of the major players actively operating in the market are F. Hoffmann-La Roche AG; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN N.V.; bioMerieux S.A.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; Danaher Corporation (Cepheid); Hologic, Inc.; Agilent Technologies, Inc.; and Illumina, Inc.

Polaris Market Research has segmented the nucleic acid amplification testing market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

PCR Tests

INAAT Tests

LCR Tests

By Application Outlook (Revenue - USD Billion, 2020-2034)

Infectious Disease Testing

Oncology Testing

Genetic & Mitochondrial Disease Testing

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Central

Reference Laboratories

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Nucleic Acid Amplification Testing Market Insights

  • 4.1. Nucleic Acid Amplification Testing Market - Market Snapshot
  • 4.2. Nucleic Acid Amplification Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Prevalence of Infectious Diseases
      • 4.2.1.2. Increasing Incidence of Genetic Disorders
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and need for specialized equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Nucleic Acid Amplification Testing Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nucleic Acid Amplification Testing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. PCR Tests
    • 5.3.1. Global Nucleic Acid Amplification Testing Market, by PCR Tests, by Region, 2020-2034 (USD Billion)
  • 5.4. INAAT Tests
    • 5.4.1. Global Nucleic Acid Amplification Testing Market, by INAAT Tests, by Region, 2020-2034 (USD Billion)
  • 5.5. LCR Tests
    • 5.5.1. Global Nucleic Acid Amplification Testing Market, by LCR Tests, by Region, 2020-2034 (USD Billion)

6. Global Nucleic Acid Amplification Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Infectious Disease Testing
    • 6.3.1. Global Nucleic Acid Amplification Testing Market, by Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Tensor
    • 6.4.1. Global Nucleic Acid Amplification Testing Market, by Deep Tensor, by Region, 2020-2034 (USD Billion)
  • 6.5. Oncology Testing
    • 6.5.1. Global Nucleic Acid Amplification Testing Market, by Oncology Testing, by Region, 2020-2034 (USD Billion)
  • 6.6. Genetic & Mitochondrial Disease Testing
    • 6.6.1. Global Nucleic Acid Amplification Testing Market, by Genetic & Mitochondrial Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Nucleic Acid Amplification Testing Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Nucleic Acid Amplification Testing Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Central
    • 7.4.1. Global Nucleic Acid Amplification Testing Market, by Central, by Region, 2020-2034 (USD Billion)
  • 7.5. Reference Laboratories
    • 7.5.1. Global Nucleic Acid Amplification Testing Market, by Reference Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Nucleic Acid Amplification Testing Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Nucleic Acid Amplification Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Nucleic Acid Amplification Testing Market - North America
    • 8.3.1. North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Nucleic Acid Amplification Testing Market - U.S.
      • 8.3.4.1. U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Nucleic Acid Amplification Testing Market - Canada
      • 8.3.5.1. Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Nucleic Acid Amplification Testing Market - Europe
    • 8.4.1. Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Nucleic Acid Amplification Testing Market - UK
      • 8.4.4.1. UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Nucleic Acid Amplification Testing Market - France
      • 8.4.5.1. France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Nucleic Acid Amplification Testing Market - Germany
      • 8.4.6.1. Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Nucleic Acid Amplification Testing Market - Italy
      • 8.4.7.1. Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Nucleic Acid Amplification Testing Market - Spain
      • 8.4.8.1. Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Nucleic Acid Amplification Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Nucleic Acid Amplification Testing Market - Russia
      • 8.4.10.1. Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Nucleic Acid Amplification Testing Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Nucleic Acid Amplification Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Nucleic Acid Amplification Testing Market - China
      • 8.5.4.1. China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Nucleic Acid Amplification Testing Market - India
      • 8.5.5.1. India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Nucleic Acid Amplification Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Nucleic Acid Amplification Testing Market - Japan
      • 8.5.7.1. Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Nucleic Acid Amplification Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Nucleic Acid Amplification Testing Market - South Korea
      • 8.5.9.1. South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Nucleic Acid Amplification Testing Market - Australia
      • 8.5.10.1. Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Nucleic Acid Amplification Testing Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Nucleic Acid Amplification Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Nucleic Acid Amplification Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Nucleic Acid Amplification Testing Market - UAE
      • 8.6.5.1. UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Nucleic Acid Amplification Testing Market - Israel
      • 8.6.6.1. Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Nucleic Acid Amplification Testing Market - South Africa
      • 8.6.7.1. South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Nucleic Acid Amplification Testing Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Nucleic Acid Amplification Testing Market - Latin America
    • 8.7.1. Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Nucleic Acid Amplification Testing Market - Mexico
      • 8.7.4.1. Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Nucleic Acid Amplification Testing Market - Brazil
      • 8.7.5.1. Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Nucleic Acid Amplification Testing Market - Argentina
      • 8.7.6.1. Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Nucleic Acid Amplification Testing Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Becton, Dickinson and Company (BD)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. bioMerieux S.A.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher Corporation (Cepheid)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hologic, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Illumina, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. QIAGEN N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제